Abstract

To compare cryopreserved human corneal endothelial cells (HCECs) grown in human serum-supplemented media (HS-SM) with cryopreserved HCECs grown in fetal bovine serum-supplemented media (FBS-SM). Three pairs of human corneas from donors aged 8, 28, and 31 years were obtained from the eye bank. From each pair, one cornea was used to start a HCEC culture using HS-SM; the other cornea was grown in FBS-SM. On reaching confluence, the six cell populations were frozen using 10% dimethyl sulfoxidecontaining medium. Thawed cells grown in HS-SM were compared with those grown in FBS-SM with respect to morphology, growth curves, immunohistochemistry, real time-reverse transcriptase polymerase chain reaction (RT-PCR) for endothelial cell markers, and detachment time. No difference in morphology was observed for cells grown in the two media before or after cryopreservation. By growth curves, cell counts after thawing were similar in both media, with a slight trend toward higher cell counts in FBS-SM. Cells grown in both the media demonstrated a similar expression of endothelial cell markers when assessed by immunohistochemistry, although HCEC marker gene expression was higher in cells grown in HS-SM than in those grown in FBS-SM as assessed by RT-PCR. With FBS-SM, there was a tendency of longer detachment time and lower cell passages. HS-SM was similar to FBS-SM for cryopreservation of cultured HCECs as assessed by analysis of cell morphology, proliferation, and protein expression, although marker gene expression was higher in cells grown in HS-SM than in those grown in FBS-SM. Detachment time was longer with FBS-SM and in lower passages.

Highlights

  • Since Stocker et al[1] established a human corneal endothelial cell (HCEC) culture, the potential for cell therapy to treat corneal endothelial dysfunction using human corneal endothelial cells (HCECs) has demonstrated continuous development[2,3,4,5,6,7,8]

  • Typical endothelial-cell polygonal morphology was observed for cells grown in both FBS- and human serum-supplemented medium (HS-SM) at passage 1 (P1) for all three pairs of cell populations, and a typical spindle-shape transformation

  • reverse transcriptase polymerase chain reaction (RT-Polymerase chain reaction (PCR)) of tight junction protein 1 (TJP1); ATPase, Na+/K+ transporting, alpha 1 polypeptide (ATP1A1); and glypican 4 (GPC4) of passage-2 HCECs cultured in media with fetal bovine serum (FBS-SM) and human serum (HS-SM)

Read more

Summary

Introduction

Since Stocker et al[1] established a human corneal endothelial cell (HCEC) culture, the potential for cell therapy to treat corneal endothelial dysfunction using HCECs has demonstrated continuous development[2,3,4,5,6,7,8]. The limitations associated with this therapy can be basically divided into two major areas: those related to culturing the cells, such as proliferation, cellular senescence, and fibroblastic transformation and those related to the logistics and techniques for transplanting the cells[2,3,4,5,6,7,8].

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.